Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
R Zhao, S Ren, C Li, K Guo, Z Lu… - Cancer …, 2023 - mdanderson.elsevierpure.com
Background: Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian… - Cancer …, 2023 - search.ebscohost.com
Background: Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
[HTML][HTML] Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian, J He… - Cancer …, 2023 - ncbi.nlm.nih.gov
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian, J He… - Cancer …, 2023 - search.proquest.com
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian, J He… - Cancer …, 2022 - europepmc.org
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
R Zhao, S Ren, C Li, K Guo, Z Lu, L Tian, J He… - Cancer …, 2022 - europepmc.org
Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …